Evidence map›Paper›PMID 31150447›Full record

ArticlePloS one2019

HIV testing and the HIV care continuum among sub-Saharan African men who have sex with men and transgender women screened for participation in HPTN 075.

Theo G M Sandfort, Karen Dominguez, Noel Kayange, Arthur Ogendo, Ravindre Panchia, Ying Q Chen, Wairimu Chege, Vanessa Cummings, Xu Guo, Erica L Hamilton and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 4 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 4 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Determinants of antiretroviral therapy adherence among transgender women in South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 4 countries.

Theo G M SandfortHIV Center for Clinical and Behavioral Studies, Columbia University, New York, NY, United States of America.ORCID 0000-0002-4986-1739
Karen DominguezDesmond Tutu HIV Centre, UCT Medical School, Cape Town, South Africa.
Noel KayangeJohns Hopkins Medical College, Malawi, Blantyre, Malawi.
Arthur OgendoKenya Medical Research Institute (KEMRI) CDC, Kisumu, Kenya.
Ravindre PanchiaPerinatal HIV Research Unit, Univ. of the Witwatersrand, Soweto HPTN CRS, Soweto, South Africa.
Ying Q ChenVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA, United States of America.
Wairimu ChegeNational Institute of Allergy and Infectious Disease, National Institutes of Health (NIH), Bethesda MD, United States of America.
Vanessa CummingsDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.ORCID 0000-0001-7325-1837
Xu GuoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA, United States of America.
Erica L HamiltonScience Facilitation Department, FHI, Durham, NC, United States of America.ORCID 0000-0003-1174-9263
Michael StirrattNational Institute of Mental Health, Division of AIDS Research, Bethesda MD, United States of America.ORCID 0000-0001-5243-9312
Susan H EshlemanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.ORCID 0000-0002-4587-791X
Fred Hutch Cancer Center · USJohns Hopkins University · USColumbia University · USDesmond Tutu HIV Foundation · ZAFamily Health International 360 · USKenya Medical Research Institute · KENational Institutes of Health · USOffice of AIDS Research · USUniversity of Malawi · MWUniversity of the Witwatersrand · ZA

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Emory HIV/AIDS Clinical Trials UnitUM1AI069418 · NIAID · EMORY UNIVERSITY · PI Moises Arturo Huaman Joo, Colleen F Kelley · 2012 to 2026
$46.0M
The Malawi Clinical Trials UnitUM1AI069518 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKY M JENNINGS, TAHA E TAHA · 2012 to 2026
$43.8M
Soweto Clinical Trials UnitUM1AI069453 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI Glenda E Gray, Lerato Mohapi · 2012 to 2026
$40.9M
BIOMEDICAL INFORMATION DEVELOPMENT IN SUB-SAHARAN AFRICAD43TW001081 · FIC · JOHNS HOPKINS UNIVERSITY · PI TAHA, TAHA E · 1998 to 2003
$435k
FIC NIH HHS D43 TW001081NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069418NIAID NIH HHS UM1 AI069453NIAID NIH HHS UM1 AI069518NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

Throughout the world, men who have sex with men (MSM) are at increased risk for HIV infection compared to heterosexual men. Little is known about awareness of HIV infection and other gaps in the HIV care continuum for MSM, especially in sub-Saharan Africa (SSA). This information is urgently needed to address the HIV epidemic in this population. This study assessed gaps in the HIV care continuum among persons screened for participation in a multi-country prospective study that evaluated the feasibility of recruiting and retaining MSM for HIV prevention studies in SSA (HIV Prevention Trials Network (HPTN) 075, conducted in four cities in Kenya, Malawi, and South Africa). Participants were recruited using site-specific strategies, that included outreach and informal networks. Transgender women (TW) were eligible to participate. During screening, 601 MSM and TW were tested for HIV infection and asked about prior HIV testing, HIV status, engagement in care, and HIV treatment. Viral load testing and retrospective antiretroviral (ARV) drug testing were performed for HIV-infected participants. Most participants (92.2%) had a prior HIV test; 42.1% were last tested >6 months earlier. HIV prevalence was 30.4%. HIV infection was associated with older age and identifying as female or transgender; 43.7% of the HIV-infected participants were newly diagnosed, especially younger persons and persons with a less recent HIV test. Almost a third of previously-diagnosed participants were not linked to care. Most participants (88.7%) in care were on ARV treatment (ART). Only about one-quarter of all HIV-infected participants were virally suppressed. These findings demonstrate substantial prevalence of undiagnosed HIV infection and sub-optimal HIV care engagement among MSM and TW in SSA. Increased HIV testing frequency and better linkage to care represent critical steps in preventing further HIV transmission in this population. Once in care, gaps in the HIV care continuum appear less critical.

Indexed as

AdolescentAdultAfrica South of the SaharaAnti-Retroviral AgentsBlack PeopleContinuity of Patient CareFemaleHIV-1HIV InfectionsHumansMaleMass ScreeningPrevalenceProfessional Practice GapsProspective StudiesRetrospective StudiesAnti-Retroviral Agents

Identifiers

PMID31150447
PMCPMC6544251
OpenAlexW2947789972

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.